DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Wendtner CM, Hillmen P, Mahadevan D et al.
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
Leuk Lymphoma 2012;
53: 417-423
We do not assume any responsibility for the contents of the web pages of other providers.